<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[NeoStem Inc. | Company News & Executive Profiles - NBS | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/neostem+inc..html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for NeoStem Inc.]]></description>
	<s:counts start="0" returned="10" found="17" />
	<language>en-us</language>
	<item>
		<title><![CDATA[NeoStem Closes China Biopharma Acquisition to Boost Revenues]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F170797-neostem-closes-china-biopharma-acquisition-to-boost-revenues%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  NeoStem, Inc. NBS announced it has closed its acquisition of China Biopharmaceuticals Holdings, Inc. (CHBP.OB). China Biopharma&#8217;s sole asset is a 51% stake in Suzhou Erye Pharmaceutical Co., a 50-year old pharmaceutical company that expects to generate $60 million in revenue and net income of $12...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 03 Nov 2009 05:05:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem Moves Ahead with China Biopharma Acquisition]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F165694-neostem-moves-ahead-with-china-biopharma-acquisition%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  NeoStem, Inc. NBS reported the SEC accepted its registration proposal to acquire China Biopharmaceutical Holdings (CHBP.OB) in an all-stock transaction. China Biopharma&#8217;s only asset is a 51% interest in Suzhou Erye Pharmaceutical Co., a generic drug manufacturer that in 2008 produced $50 million in revenues and...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 09 Oct 2009 03:28:29 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem: A 3-Part China Merger Strategy]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F165469-neostem-a-3-part-china-merger-strategy%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: NeoStem (AMEX: NBS) is an innovator and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications that is expanding into research, medical tourism, and China for the commercialization of anti-aging / cosmetic medicine...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 08 Oct 2009 02:53:55 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem: Pending Merger Key to China Growth Strategy]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F161910-neostem-pending-merger-key-to-china-growth-strategy%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: NeoStem (AMEX: NBS) is an innovator and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 16 Sep 2009 11:27:53 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem Raises an Additional $4 Million]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F147011-neostem-raises-an-additional-4-million%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  NeoStem, Inc. NBS has raised another $4 million from institutional and private investors. The terms of the funding were the same as those for the company&#8217;s previous fund raising, an $11 million private placement in April involving three Asia-based investors.   Also, affiliates of Suzhou...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 05 Jul 2009 05:41:55 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem Makes Good on China Medical Tourism Initiative with Stem Cell Deal]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F143343-neostem-makes-good-on-china-medical-tourism-initiative-with-stem-cell-deal%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  NeoStem, Inc. NBS, a company built on collection and storage of adult stem cells, signed an exclusive 10-year agreement with Enhance BioMedical Holdings Limited of Shanghai. Using NeoStem developed techniques, Enhance will build a stem cell collection and treatment network. The facilities are targeted for Shanghai,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 15 Jun 2009 10:42:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F141493-neostem-pro-active-research-initiates-coverage-with-speculative-buy%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: NeoStem, Inc. (AMEX:NBS) is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 05 Jun 2009 04:57:03 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem: Expanding Beyond Stem Cell Banking]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F138147-neostem-expanding-beyond-stem-cell-banking%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: NeoStem (AMEX:NBS) is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 18 May 2009 01:10:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem Acquires Asia Rights to Stem Cell Treatment]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F137029-neostem-acquires-asia-rights-to-stem-cell-treatment%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:   NeoStem, Inc. NBS in-licensed the Asia rights for Regenrexx, a process that uses a patient&#8217;s own mesenchymal stem cells to regenerate joints and bones as an alternative to surgery. After isolating mesenchymal stem cells from bone marrow, the process cultures them for two to three...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 11 May 2009 10:14:48 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
	<item>
		<title><![CDATA[NeoStem Makes Headway in Stem Cell Industry]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F135710-neostem-makes-headway-in-stem-cell-industry%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  NeoStem, Inc. NBS in-licensed worldwide rights to Primcel, a mesenchymal bone marrow stem cell product that, in early clinical studies, shows promise of accelerating the healing of chronic wounds. NeoStem has opened adult stem cell collection sites in the US and has invested in regenerative medicine...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 06 May 2009 05:21:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/neostem+inc..html"><![CDATA[NeoStem Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NBS</category>
		<category domain="tickers">NBS</category>
	</item>
</channel>
</rss>
